CAS RN: 1351611-14-7
N-formyl-1-(4-methoxyphenyl)-7-oxo-6-(4-(2-oxopiperidin-1-yl)phenyl)-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxamide
Product Availability
Choose a grade to view its available package options.
1 package records 0 with current stock 1 grade group
Grade
97% (1)
In stock only
Batch No. Package Availability Lead Time Inquiry
Batchno.20251118
250mg
Out of stock
15 business days Inquiry
GET A QUOTE
This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 1g
Available purity: ≥95%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 1351611-14-7
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
1g
≥95%
0
Out of Stock
Shenzhen
Inquiry
1351611-14-7 / N-formyl-1-(4-methoxyphenyl)-7-oxo-6-[4-(2-oxopiperidin-1-yl)phenyl]-4,5-dihydropyrazolo[5,4-c]pyridine-3-carboxamide
Standard CAS: 1351611-14-7
Multi CAS: No
Basic Information
copy
CAS
1351611-14-7 copy
Multi CAS
No copy
Molecular Formula
C26H25N5O5 copy
Molecular Weight
487.500000 copy
Exact Mass
487.185569 copy
SMILES
COC1=CC=C(C=C1)N2C3=C(CCN(C3=O)C4=CC=C(C=C4)N5CCCCC5=O)C(=N2)C(=O)NC=O copy
InChI
InChI=1S/C26H25N5O5/c1-36-20-11-9-19(10-12-20)31-24-21(23(28-31)25(34)27-16-32)13-15-30(26(24)35)18-7-5-17(6-8-18)29-14-3-2-4-22(29)33/h5-12,16H,2-4,13-15H2,1H3,(H,27,32,34) copy
InChIKey
RRAFWRVOUFGSEW-UHFFFAOYSA-N copy
Computed Properties
copy
Structural Parameters
Heavy atom count
36 copy
Aromatic heavy atom count
17 copy
Fraction Csp3
0.27 copy
Rotatable bonds
6 copy
H-bond acceptors
7 copy
H-bond donors
1 copy
Molar refractivity
131.67 copy
TPSA
113.84 copy
LogP / Solubility
WLOGP
2.49 copy
MLOGP
2.22 copy
XLogP3
2.4 copy
Consensus LogP
2.37 copy
Log S (ESOL)
-4.38 copy
Class (ESOL)
Slightly soluble copy
Log S (Ali)
-5.35 copy
Class (Ali)
Slightly soluble copy
Log S (SILICOS-IT)
-5.61 copy
Class (SILICOS-IT)
Slightly soluble copy
ADME
GI absorption
High copy
BBB permeant
No copy
P-gp substrate
No copy
CYP1A2 inhibitor
Yes copy
CYP2C19 inhibitor
Yes copy
CYP2C9 inhibitor
No copy
CYP2D6 inhibitor
Yes copy
CYP3A4 inhibitor
No copy
Log Kp (skin permeation)
-3.93 copy
Drug-likeness / Medicinal Chemistry
Lipinski
Yes copy
Ghose
No copy
Veber
Yes copy
Egan
Yes copy
Muegge
Yes copy
Bioavailability score
0.55 copy
Brenk alerts
1 copy
Leadlikeness
No copy
Synthetic Accessibility
5 copy